Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General
Market Cap
$552.66 Million
CN¥4.06 Billion CNY
Market Cap Rank
#10675 Global
#2413 in China
Share Price
CN¥7.99
Change (1 day)
+1.52%
52-Week Range
CN¥5.96 - CN¥8.43
All Time High
CN¥14.97
About

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablet… Read more

Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.065x

Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a cash flow conversion efficiency ratio of -0.065x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-45.73 Million) by net assets (CN¥709.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangdong Jiaying Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2024)

The table below shows the annual cash flow conversion efficiency of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥758.22 Million CN¥60.85 Million 0.080x -37.81%
2023-12-31 CN¥762.98 Million CN¥98.45 Million 0.129x +246.14%
2022-12-31 CN¥728.42 Million CN¥27.15 Million 0.037x -50.74%
2021-12-31 CN¥684.48 Million CN¥51.80 Million 0.076x -46.64%
2020-12-31 CN¥683.01 Million CN¥96.87 Million 0.142x +625.55%
2019-12-31 CN¥663.17 Million CN¥12.96 Million 0.020x -75.28%
2018-12-31 CN¥785.35 Million CN¥62.10 Million 0.079x +93.56%
2017-12-31 CN¥749.81 Million CN¥30.63 Million 0.041x -24.27%
2016-12-31 CN¥984.87 Million CN¥53.13 Million 0.054x +18.52%
2015-12-31 CN¥929.70 Million CN¥42.31 Million 0.046x -61.99%
2014-12-31 CN¥863.35 Million CN¥103.36 Million 0.120x +398.08%
2013-12-31 CN¥809.66 Million CN¥19.46 Million 0.024x +26.80%
2012-12-31 CN¥278.08 Million CN¥5.27 Million 0.019x +555.86%
2011-12-31 CN¥270.51 Million CN¥781.89K 0.003x -96.21%
2010-12-31 CN¥258.47 Million CN¥19.70 Million 0.076x -34.25%
2009-12-31 CN¥241.42 Million CN¥27.98 Million 0.116x +144.87%
2008-12-31 CN¥226.35 Million CN¥10.71 Million 0.047x -45.15%
2007-12-31 CN¥212.62 Million CN¥18.35 Million 0.086x -72.96%
2006-12-31 CN¥82.63 Million CN¥26.37 Million 0.319x +16.54%
2005-12-31 CN¥64.39 Million CN¥17.63 Million 0.274x +52.64%
2004-12-31 CN¥48.97 Million CN¥8.78 Million 0.179x --